| Hemodiafiltration with Endogenous Reinfusion with and without Acetate-Free Dialysis Solutions: Effect on ESA Requirement. | |
| | |
MedLine Citation:
|
PMID: 21242676 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background: Hemofiltrate reinfusion (HFR) is a form of hemodiafiltration (HDF) in which replacement fluid is constituted by ultrafiltrate from the patient 'regenerated' through a cartridge containing hydrophobic styrene resin. Bicarbonate-based dialysis solutions (DS) used in routine hemodialysis and HDF contain small quantities of acetate (3-5 mM) as a stabilizing agent, one of the major causes of intradialytic hypotension. Acetate-free (AF) DS have recently been made available, substituting acetate with hydrochloric acid. The impact of AF DS during HFR on Hb levels and erythropoietic-stimulating agent (ESA) requirement in chronic dialysis patients was assessed. Patients and Methods: After obtaining informed consent, 30 uremic patients treated by standard bicarbonate dialysis (BHD, DS with acetate) were randomized to treatment in 3-month cycles: first AF HFR, followed by HFR with acetate, and again AF HFR. At the beginning and end of each period, Hb and ESA requirements were evaluated. Results: A significant increase in the Hb level was observed throughout all periods of HFR versus BHD (from 11.1 to 11.86 g/dl; p = 0.04), with a significant decrease of ESA requirements from 29,500 to 25,033 IU/month (p = 0.04). Conclusion: Regardless of the presence or absence of acetate in DS, HFR per se allows a significant lowering of ESA dosage versus BHD, while at the same time increasing Hb levels. Taking for granted the clinical impact produced, HFR seems to provide a relevant decrease in end-stage renal disease patient costs. |
| | |
Authors:
|
P G Bolasco; P M Ghezzi; A Serra; L Corazza; S Murtas; M Mascia; M Cossu; R Ferrara; G Cogoni; F Cadinu; D Casu; B Contu; M Passaghe; T Ghisu; M Ganadu; F Logias |
Related Documents
:
|
23211116 - Impact of fibrinogen levels on outcomes after acute injury in patients requiring a mass... 15811146 - Predictors of glycaemic control in indigent patients presenting with diabetic ketoacido... 14720176 - Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss fro... 12818056 - Relevance of plasma d-dimer measurement in patients with acute peripheral vertigo. 16174016 - Efficacy and safety of cryoenergy in the ablation of atrioventricular reentrant tachyca... 3232956 - Biological activity of serum prolactin in patients with primary hypothyroidism. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-1-14 |
Journal Detail:
|
Title: Blood purification Volume: 31 ISSN: 1421-9735 ISO Abbreviation: - Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-1-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8402040 Medline TA: Blood Purif Country: - |
Other Details:
|
Languages: ENG Pagination: 235-242 Citation Subset: - |
Copyright Information:
|
Copyright © 2011 S. Karger AG, Basel. |
Affiliation:
|
Territorial Department of Nephrology and Dialysis, ASL 8, Cagliari, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Enhancement of Solute Removal in a Hollow-Fiber Hemodialyzer by Mechanical Vibration.
Next Document: The Impact of Residual Renal Function on Hospitalization and Mortality in Incident Hemodialysis Pati...